Search Medical Condition
Please enter condition
Please choose location

Chronic Obstructive Lung Disease Clinical Trials

A listing of Chronic Obstructive Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (156) clinical trials

The Clinical Research Center is conducting a placebo controlled study to evaluate an investigational medication for COPD. The study medication is a bio-equivalent medication to Spiriva. Your participation in the study could last up to 26 weeks and consist of up to 8 visits.

Phase N/A

A research study for former smokers both healthy and with COPD

Phase N/A

Dr. Craig LaForce and Dr. Karen Dunn are recruiting individuals 40 years and up who suffer from COPD, emphysema or Chronic bronchitis to participate in a research study, involving an investigational medication.

Phase N/A

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase

Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing

HFNC has been shown to have many advantages in the treatment of acutely hypoxemic patients, improving their clinical outcome. The exact mechanism underlying this beneficial effect is still not completely understood. Few studies have analyzed the effect of HFNC on ventilatory pattern and work of breathing. The majority of these ...

Phase N/A

Seasonal Influenza Vaccine Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

Primary Objectives: To evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of GOLD Stage C and D COPD (vs. those patients without COPD). To demonstrate immunogenicity by measuring hemagglutination inhibiting ...

Phase